CA125 and human epididymis protein 4 (HE4) are two typical TAAs in ovarian tumors, although the diagnostic discrimination value of these markers remains suboptimal due to low sensitivity for early-stage disease (21). Here, WFDC2 is linked to ovarian neoplasm.